Connor, Clark & Lunn Investment Management (CC&L)’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-93,889
Closed -$1.39M 1743
2025
Q4
$1.39M Sell
93,889
-145,857
-61% -$2.06M ﹤0.01% 1028
2025
Q3
$3.08M Buy
239,746
+20,359
+9% +$271K 0.01% 719
2025
Q2
$3.33M Buy
+219,387
New +$3.42M 0.01% 701
2024
Q4
Sell
-70,246
Closed -$1.32M 1617
2024
Q3
$1.32M Buy
+70,246
New +$1.35M 0.01% 796
2023
Q4
Sell
-30,941
Closed -$421K 1539
2023
Q3
$421K Sell
30,941
-7,541
-20% -$116K ﹤0.01% 1060
2023
Q2
$661K Buy
+38,482
New +$596K ﹤0.01% 916
2022
Q4
Sell
-108,320
Closed -$1.29M 1402
2022
Q3
$1.29M Buy
+108,320
New +$1.54M 0.01% 596
2022
Q2
Sell
-101,269
Closed -$1.31M 1188
2022
Q1
$1.31M Buy
+101,269
New +$1.34M 0.01% 608
2020
Q1
Sell
-26,402
Closed -$332K 1152
2019
Q4
$332K Buy
+26,402
New +$284K ﹤0.01% 741
2016
Q3
Sell
-204,021
Closed -$1.2M 906
2016
Q2
$1.2M Sell
204,021
-64,217
-24% -$425K 0.01% 450
2016
Q1
$1.71M Sell
268,238
-43,756
-14% -$235K 0.01% 358
2015
Q4
$2M Buy
311,994
+34,151
+12% +$214K 0.02% 341
2015
Q3
$1.61M Buy
277,843
+53,453
+24% +$396K 0.01% 326
2015
Q2
$1.96M Buy
224,390
+15,033
+7% +$126K 0.02% 244
2015
Q1
$1.67M Sell
209,357
-159,430
-43% -$1.19M 0.01% 248
2014
Q4
$2.86M Sell
368,787
-197,293
-35% -$1.44M 0.02% 199
2014
Q3
$3.67M Buy
566,080
+405,536
+253% +$3.13M 0.03% 164
2014
Q2
$1.44M Buy
160,544
+74,240
+86% +$576K 0.01% 278
2014
Q1
$639K Buy
86,304
+43,430
+101% +$263K ﹤0.01% 446
2013
Q4
$285K Sell
42,874
-49,369
-54% -$241K ﹤0.01% 611
2013
Q3
$412K Sell
92,243
-83,520
-48% -$382K ﹤0.01% 395
2013
Q2
$819K Buy
+175,763
New +$778K 0.01% 285

Other funds holding SEM

Connor, Clark & Lunn Investment Management (CC&L)'s SEM Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Select Medical (SEM) in Q1 2026, closing a stake of 93,889 shares — an estimated $1.39M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SEM in Q2 2013 and held it in 22 quarters. The position peaked at $3.67M in Q3 2014. 278 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 93,889 Select Medical shares in Q1 2026, an estimated $1.39M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Select Medical in Q2 2013 and held it in 22 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Select Medical position peaked at $3.67M in Q3 2014.
  • 278 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.